Search Results - "Bouquerel, P."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer

    Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer by Bouquerel, P, Gstalder, C, Müller, D, Laurent, J, Brizuela, L, Sabbadini, R A, Malavaud, B, Pyronnet, S, Martineau, Y, Ader, I, Cuvillier, O

    Published in Oncogenesis (New York, NY) (14-03-2016)
    “…The sphingosine kinase-1/sphingosine 1-phosphate (SphK1/S1P) signaling pathway has been reported to modulate the expression of the canonical transcription…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    1163 POSTER A Therapeutic Sphingosine 1-phosphate Antibody Inhibits Intratumoral Hypoxia and Sensitizes to Standard Chemotherapy in a Preclinical Model of Prostate Cancer

    1163 POSTER A Therapeutic Sphingosine 1-phosphate Antibody Inhibits Intratumoral Hypoxia and Sensitizes to Standard Chemotherapy in a Preclinical Model of Prostate Cancer by Cuvillier, O, Ader, I, Bouquerel, P, Malavaud, B, Sabbadini, R.A

    Published in European journal of cancer (1990) (2011)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    42 A therapeutic sphingosine 1-phosphate antibody inhibits intratumoural hypoxia and sensitizes to chemotherapy in prostate cancer animal model

    42 A therapeutic sphingosine 1-phosphate antibody inhibits intratumoural hypoxia and sensitizes to chemotherapy in prostate cancer animal model by Cuvillier, O, Ader, I, Bouquerel, P, Golzio, M, Malavaud, B, Sabbadini, R.A

    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Effect of a therapeutic sphingosine 1-phosphate antibody on intratumoral hypoxia and sensitivity to standard chemotherapy in prostate cancer animal model

    Effect of a therapeutic sphingosine 1-phosphate antibody on intratumoral hypoxia and sensitivity to standard chemotherapy in prostate cancer animal model by Cuvillier, O., Ader, I., Bouquerel, P., Malavaud, B., Sabbadini, R. A.

    Published in Journal of clinical oncology (01-03-2011)
    “…Abstract only 24 Background: Hypoxia promotes neovascularization, metastasis, growth and resistance to treatments. The activation of HIF-1α has been identified…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2[alpha] expression and activity in cancer

    Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2[alpha] expression and activity in cancer by Bouquerel, P, Gstalder, C, Müller, D, Laurent, J, Brizuela, L, Sabbadini, R A, Malavaud, B, Pyronnet, S, Martineau, Y, Ader, I, Cuvillier, O

    Published in Oncogenesis (New York, NY) (01-03-2016)
    “…The sphingosine kinase-1/sphingosine 1-phosphate (SphK1/S1P) signaling pathway has been reported to modulate the expression of the canonical transcription…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    R163 - Oral, Club Mex-H A sphingosine 1-phosphate antibody inhibits intratumoral hypoxia and sensitizes to docetaxel in prostate cancer animal model

    R163 - Oral, Club Mex-H A sphingosine 1-phosphate antibody inhibits intratumoral hypoxia and sensitizes to docetaxel in prostate cancer animal model by Ader-Perarnau, I., Bouquerel, P., Golzio, M., Malavaud, B., Sabbadini, R.A., Cuvillier, O.

    Published in Bulletin du cancer (01-10-2010)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: